(Q36380983)

13 August 2017

1 reference

title

Mechanisms of Raynaud's disease (English)

1 reference

13 August 2017

John P Cooke

1

1 reference

PubMed ID

16444858

13 August 2017

Janice M Marshall

series ordinal

2

1 reference

13 August 2017

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

10

1 reference

13 August 2017

4

1 reference

13 August 2017

293-307

1 reference

Nitric oxide synthase: role in the genesis of vascular disease

13 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Familial aggregation of primary Raynaud's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Sex differences in control of cutaneous blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Menopausal hot flashes: thermoregulatory, cardiovascular, and circulating catecholamine and LH changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Sexual dimorphism in prostanoid-potentiated vascular contraction: roles of endothelium and ovarian steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Role of alpha-adrenoceptor subtypes mediating sympathetic vasoconstriction in human digits

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Alpha-adrenoceptors in the vessels of human finger skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Role of digital artery adrenoceptors in Raynaud's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Sarcoplasmic reticulum and the temperature-dependent contraction of smooth muscle in calcium-free solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Limited microsurgical arteriolysis for complications of digital vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

The cutaneous vasoconstrictor response to venous stasis is normal in subjects with primary Raynaud's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Habituation of the cold pressor response in normo- and hypertensive human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Digital vascular responses and serum endothelin-1 concentrations in primary and secondary Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Oxidative stress and cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Contribution of prostanoids to endothelium-dependent vasodilatation in the digital circulation of women with primary Raynaud's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Menopause is associated with endothelial dysfunction in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Vasoconstrictor products of cyclo-oxygenase activity limit acetylcholine-induced cutaneous vasodilatation in young men

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Estrogen modulation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

The Association of Estrogen Replacement Therapy and the Raynaud Phenomenon in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

The effects of thromboxane A2 inhibition (picotamide) and angiotensin II receptor blockade (losartan) in primary Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Further studies on the actions of endothelin-1 on blood flow in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Mediation by prostaglandins of the nitric oxide-induced neurogenic vasodilatation in rat skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

The effect of the nitric oxide synthase inhibitor N-nitro-L-arginine-methyl ester on neuropeptide-induced vasodilation and protein extravasation in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

Venodilation in Raynaud's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM639RA

10.1191/1358863X05VM639RA

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16444858